M1 Kliniken AG acquires 48% of HAEMATO AG

• M1 Kliniken AG acquires about 48 % of the share capital of HAEMATO AG from MPH Health Care AG. Transfer of the HAEMATO shares within the framework of a capital increase through contribution in kind
• Focus of both companies on their respective core competencies beauty and products/trades

Berlin, 10.06.2020 - The management boards of M1 Kliniken AG and MPH Health Care AG today signed an agreement for the acquisition of all HAEMATO AG shares owned by MPH Health Care AG by M1 Kliniken AG. MPH Health Care AG is contributing the shares of HAEMATO AG to M1 Kliniken AG within the framework of a capital increase through contribution in kind. M1 Kliniken AG has already resolved on the relevant resolutions for the implementation of the capital increase through contribution in kind by a total of 2,143,403 new M1 shares. The takeover will be effective as of July 1, 2020.

Once the transaction is implemented, M1 Kliniken AG and HAEMATO AG will be able to strengthen their respective core competencies. In the future, the M1 Group will concentrate exclusively on the operation of the specialist centres and the further growth of the international network to approximately 100 locations by 2023/2024. HAEMATO AG will focus even more strongly on the area of pharmaceutical and medical product trading and the development of private labels in the self-payer sector.

M1 Kliniken AG expects consolidated sales of more than €150 million in fiscal year 2020 and €250-300 million in fiscal year 2021 after the implementation of the transaction.
Patrick Brenske, CEO of M1 Kliniken AG comments on the transaction: "In recent years we have already achieved clear market leadership in the beauty treatment sector in Germany and in the medium term we are aiming for a comparable market position internationally. Through the clear focus on our beauty-business activities and their sustainable growth, we will be in an even better position to offer the highest quality at reasonable prices in the long-term".